Retinoblastoma: unveiling molecular pathogenesis and pioneering organoid-driven therapeutic innovations
Crossref DOI link: https://doi.org/10.1186/s13287-026-04951-4
Published Online: 2026-03-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Hua
Jin, Chenrui
Text and Data Mining valid from 2026-03-04
Version of Record valid from 2026-03-05
Article History
Received: 17 October 2025
Accepted: 25 February 2026
First Online: 4 March 2026
Declarations
:
: Not applicable.
: The authors declare no competing interests.